| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/27/2001 | CN1301182A Solid preparations for oral administration of drugs relating to genes |
| 06/27/2001 | CN1301179A Hemoglobin-polysaccharide conjugates |
| 06/27/2001 | CN1301178A Solution comprising prostaglandins and benzyl alcohol |
| 06/27/2001 | CN1301177A Anti-inflammatory eye drops |
| 06/27/2001 | CN1301175A Humanized antibodies that recognize verotoxin II and cell line producing same |
| 06/27/2001 | CN1301174A Method of inducing an anti-tumor response against a lung metastasis in a melanoma patient |
| 06/27/2001 | CN1301173A Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 06/27/2001 | CN1301168A Therapeutic dinucleotide and derivatives |
| 06/27/2001 | CN1301167A Treatment of organophosphate poisoning |
| 06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
| 06/27/2001 | CN1301165A Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 06/27/2001 | CN1301164A New treatment for nervous disorders |
| 06/27/2001 | CN1301163A Controlled release peroral compositions of levosimendan |
| 06/27/2001 | CN1301162A Method for combating obesity |
| 06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
| 06/27/2001 | CN1301160A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal frailty |
| 06/27/2001 | CN1301159A Cabergoline and pramipexole: new uses and combinations |
| 06/27/2001 | CN1301158A Compositions for the treatment of HIV and other viral infections |
| 06/27/2001 | CN1301157A Sustained release preparations |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301155A Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivative process for preparing the same |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/27/2001 | CN1301153A INhibition of IgA production |
| 06/27/2001 | CN1301152A Transdermal therapeutic system containing pergolide |
| 06/27/2001 | CN1301149A Delavirdine tablet formulation |
| 06/27/2001 | CN1301148A Pharmaceutical preparation containing levothyroxine sodium |
| 06/27/2001 | CN1301146A Topical hormonal composition with systemic effect |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1300620A Process for preparing snuff to treat hepatitis B |
| 06/27/2001 | CN1300619A Process for preparing snuff to treat hepatitis A |
| 06/27/2001 | CN1300613A Process for preparing 'Weilinsan' |
| 06/27/2001 | CN1300595A Nucleic acid oral liquid for animals and its preparing process |
| 06/27/2001 | CN1300594A Ginsengdiol histsaponin and application of its composition in treating hematopathy |
| 06/27/2001 | CN1300593A Medical application of pseudo-paraquilon F11 |
| 06/27/2001 | CN1300592A Method for treating tumor by increasing white cells via TPA and intravenous injection |
| 06/27/2001 | CN1300591A Hypoglycemic Chinese medicine 'Yanzizhang' and its preparing process |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/27/2001 | CN1300562A Composition containing fat-soluble vitamins |
| 06/27/2001 | CN1067722C Adenoviral vectors |
| 06/27/2001 | CN1067687C Polymorphic foams of growth hormone secretagogue |
| 06/27/2001 | CN1067685C Pyridazinoquinoline compounds |
| 06/27/2001 | CN1067684C Imidazo [1,5-1] quinolines for treatment of anxiety and sleep disorders |
| 06/27/2001 | CN1067683C Substituted morpholine derivatives and their use as therapeutic agents |
| 06/27/2001 | CN1067682C Anti-tumor compounds, pharmaceutica compositions, methods for preparation thereof and for treatment. |
| 06/27/2001 | CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound |
| 06/27/2001 | CN1067586C Composite medicinal injection for hemiparalysis |
| 06/27/2001 | CN1067583C Chinese medicine for treating piles and its preparation |
| 06/27/2001 | CN1067572C Sprayed powder for treating macerative erosive beriberi |
| 06/27/2001 | CN1067550C Calcium receptor active molecules |
| 06/27/2001 | CN1067549C Water soluble gossypol preparation and method therefor |
| 06/27/2001 | CN1067548C Preparation for beta-carotene or carotene micro capsule and application thereof |
| 06/27/2001 | CN1067531C Health-care chitosan-chitin food |
| 06/26/2001 | US6252116 Intermediates useful in a process for synthesizing COX-2 inhibitors |
| 06/26/2001 | US6252113 O-etherification of p-(2-methoxyethyl)-phenol with aqueous epichlorohydrin, evaporation of excess epichlorohydrin, distillation, then amination with isopropylamine to yield metoprolol product |
| 06/26/2001 | US6252093 Total synthesis of antitumor acylfulvenes |
| 06/26/2001 | US6252091 Protecting a diol lactone; acylation; in presence of n-methylimidazole |
| 06/26/2001 | US6252090 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/26/2001 | US6252086 4-alkenyl-and 4-alkynyloxindoles |
| 06/26/2001 | US6252082 Cardiovascualr disorders |
| 06/26/2001 | US6252080 Herpes, cytomegalo virus |
| 06/26/2001 | US6252078 Fungicides for the control of take-all disease of plants |
| 06/26/2001 | US6252070 Reacting aryl bromide with butyllithium and zinc bromide to give aryl zinc bromide; reacting with corresponding benzothiazine compound |
| 06/26/2001 | US6252063 Salt forming using alkali metal compound |
| 06/26/2001 | US6252055 Generating immunoglobulins; filter immunoglobulin solution through membrane, cycle filtrate through membrane, recover immunoglobulin |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251956 Combination progestin oral contraceptive regimen |
| 06/26/2001 | US6251953 Beta-carotene therapy of individuals having abnormal immunological and serological indices, and individuals having infections and diseases causing changes therein |
| 06/26/2001 | US6251952 Method of using lachrymatory agents for moisturizing the eyes |
| 06/26/2001 | US6251950 Administering to the patient an aliphatic-propargylamine or salt for the treatment of acute and chronic diseases in which cell death occurs by apoptosis or for the treatment of premature degeneration of cells in mammals |
| 06/26/2001 | US6251948 Trisubstituted guanidine useful for treating diseases of the nervous system in which the pathophysiology of the disease involves excessive excitation of nerve cells by agonists of glutamate/n-methyl-d-aspartate receptor |
| 06/26/2001 | US6251946 Branched chain fatty acids, their derivatives and use in the treatment of central nervous system disorders |
| 06/26/2001 | US6251945 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 06/26/2001 | US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy |
| 06/26/2001 | US6251943 Method of treating or preventing septic shock by administering a MEK inhibitor |
| 06/26/2001 | US6251942 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 06/26/2001 | US6251941 Use of inhaled retinoids in the prevention of cancer |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251935 Administration of a racemic alpha-lipoic acid, enantiomers and pharmaceutically acceptable salts, amides, esters or thioester, in reduced or oxidized form as antimigraine agent |
| 06/26/2001 | US6251931 Oleamide agonists and as inhibitor of fatty acid amide hydrolase for inhibition of gap junction-mediated chemical and electrical transmission in glial cells of the animal |
| 06/26/2001 | US6251930 Treating patients suffering from cystic fibrosis by administering certain heterocyclic nitrogen containing compounds |
| 06/26/2001 | US6251929 Administering to a patient a hydantoin derivatives and salts as therapeutic and preventive agents for intractable vasculitis such as malignant rheumatoid arthritis(mra), periarteritis nodosa, wegener's granulomatosis etc. |
| 06/26/2001 | US6251928 Treatment of alzheimer's disease employing inhibitors of cathepsin D |
| 06/26/2001 | US6251927 Treating sickle cell anemia using protected forms of organic aldehydes |
| 06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251924 Pharmaceutical composition |
| 06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 06/26/2001 | US6251921 Administering thrombin inhibiting diamine compound to mammal |
| 06/26/2001 | US6251920 Administering tamoxifen or its structural analogs for prophylaxis and therapy of atherosclerosis, thrombosis, myocardial infarction and stroke |
| 06/26/2001 | US6251917 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 06/26/2001 | US6251916 For therapy of pain |
| 06/26/2001 | US6251915 Administering to male warm-blooded animal anti-cancer agent comprising n-(1-methyl-1-(4-methoxyphenyl)ethyl)-3-oxo-4-aza-5.alpha. -androst-1-ene-17.beta.-carboxamide or its salt or ester |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251911 Pyrimidine derivatives and processes for the preparation thereof |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251908 Piperazine derivatives |
| 06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |